Fullerton Fund Management’s Boston Scientific BSX Stock Holding History

Fullerton Fund Management’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$200K	Sell	3,195 -594,979	-99%	-$47.6M	0.02%	116
2025 Q4	$57M	Buy	598,174 +387,761	+184%	+$38M	2.49%	15
2025 Q3	$20.5M	Sell	210,413 -495,626	-70%	-$51.3M	0.79%	28
2025 Q2	$75.8M	Buy	706,039 +27,188	+4%	+$2.75M	3.07%	10
2025 Q1	$68.5M	Sell	678,851 -874,305	-56%	-$88M	4.4%	5
2024 Q4	$139M	Buy	1,553,156 +533,346	+52%	+$47M	4.85%	8
2024 Q3	$85.5M	Buy	1,019,810 +812,742	+393%	+$64.1M	3.59%	8
2024 Q2	$15.9M	Buy	207,068 +7,159	+4%	+$524K	0.72%	32
2024 Q1	$13.7M	Buy	+199,909	New	+$12.9M	0.65%	34
2023 Q3	–	Sell	-27,817	Closed	-$1.5M	–	59
2023 Q2	$1.5M	Buy	+27,817	New	+$1.45M	0.11%	55

Other funds holding BSX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fullerton Fund Management's BSX Position: Q1 2026 in Review

Fullerton Fund Management reduced its Boston Scientific (BSX) stake by 99% in Q1 2026, selling an estimated $47.6M and leaving 3,195 shares worth $200K. The position accounts for 0.02% of the portfolio, ranked #116.

Fullerton Fund Management first reported a position in BSX in Q2 2023 and has held it in 10 quarters since. The position peaked at $139M in Q4 2024. 1,668 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

Fullerton Fund Management held 3,195 shares of Boston Scientific worth $200K as of Q1 2026.
Fullerton Fund Management sold 594,979 Boston Scientific shares in Q1 2026, an estimated $47.6M.
Boston Scientific made up 0.02% of Fullerton Fund Management's portfolio in Q1 2026, its #116 holding.
Fullerton Fund Management first reported a position in Boston Scientific in Q2 2023 and has held it in 10 quarters since.
Fullerton Fund Management's Boston Scientific position peaked at $139M in Q4 2024.
1,668 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on Fullerton Fund Management's 13F filing for Q1 2026, filed 15 May 2026.